Centre Proposes 10 New Import Entry Points for Medicines and Medical Devices Across India
The Union Health Ministry has proposed expanding India's authorised import network for medicines and medical devices by adding 10 new entry points across the country. The proposed expansion includes Noida International Airport and several inland container depots located in important industrial and logistics centres.
The move is intended to make it easier for pharmaceutical companies, medical device manufacturers and importers to bring healthcare products into India. By adding more authorised locations, the government aims to provide businesses with additional options for clearing imported consignments closer to their warehouses, manufacturing facilities and distribution centres.
The proposal is part of a draft amendment to the Drugs Rules, 1945. If the amendment is finalised, the additional locations could become part of India's authorised network for importing medicines and medical devices.
Noida International Airport Among Proposed Locations
Noida International Airport is among the major locations included in the proposed expansion. Its addition could provide another entry option for companies importing medicines and medical devices through air cargo.
The proposal also includes several inland container depots across different states. These facilities play an important role in handling imported goods and connecting inland industrial centres with ports and other transportation networks.
The proposed locations have been selected across regions with significant industrial, manufacturing and logistics activities. The expansion is expected to give importers greater flexibility in choosing suitable entry points for their consignments.
Eight Inland Container Depot Locations Proposed
The draft amendment identifies several inland container depots in Haryana, Uttar Pradesh, Gujarat, Telangana and Karnataka.
In Haryana, the proposed locations are Sonipat, Piyala and Harsaru. These facilities would provide additional import entry options for businesses operating in and around the state's industrial areas.
Dadri in Uttar Pradesh is another location included in the proposal. Its addition could support companies handling imported healthcare products in the surrounding industrial and logistics regions.
In Gujarat, the government has proposed adding Gandhidham and Mundra to the authorised import network. These locations are important to the state's logistics and cargo-handling activities.
The proposal also includes Sanath Nagar and Thimmapur in Hyderabad, Telangana. These locations could provide additional options for companies involved in importing and distributing medicines and medical devices in the region.
Whitefield in Bengaluru, Karnataka, has also been proposed as an entry point. In addition, the Bommasandra Special Economic Zone in Karnataka is included in the draft amendment.
Together with Noida International Airport, these locations form the proposed expansion of India's authorised import network.
Expected Benefits for Pharmaceutical and Medical Device Companies
The proposed expansion is expected to make the import process more convenient for companies operating in the pharmaceutical and medical device sectors.
At present, businesses may need to transport imported consignments over longer distances after they enter the country through authorised locations. This can increase logistics expenses and lead to delays before products reach warehouses, manufacturing facilities or distribution centres.
Adding more entry points could help companies select locations closer to their business operations. This may reduce the distance between import clearance facilities and the final destinations of imported products.
The proposed changes could also provide greater flexibility in managing supply chains. Companies may be able to plan transportation more efficiently by selecting suitable entry points based on the location of their facilities and distribution networks.
For businesses handling medical devices and medicines, timely movement of imported products is important for maintaining supply operations. Additional authorised locations could therefore help improve logistics efficiency, subject to the applicable import and regulatory requirements.
Draft Amendment to Drugs Rules, 1945
The proposed expansion is being introduced through a draft amendment to the Drugs Rules, 1945. These rules form part of India's regulatory framework for drugs and related import procedures.
The Health Ministry's proposal identifies the additional locations that could be authorised for importing medicines and medical devices. As the amendment is currently at the draft stage, the proposed locations should not yet be treated as fully approved operational entry points under the amended rules.
The final implementation will depend on the completion of the applicable regulatory process and notification of the amendment.
The proposal reflects an effort to expand the infrastructure available for handling imported healthcare products. It could also support businesses that depend on international supply chains for medicines, medical equipment and other healthcare-related products.
Expansion Could Strengthen Import Logistics
The addition of more authorised entry points could help improve the movement of imported healthcare products across different parts of India. By including locations in industrial and logistics centres, the government aims to make import-related operations more accessible to businesses.
The proposed network covers several important regions, including Haryana, Uttar Pradesh, Gujarat, Telangana and Karnataka. The inclusion of Noida International Airport could also offer another option for air cargo imports.
For pharmaceutical companies and medical device importers, the availability of additional entry points may help reduce transportation distances, improve supply-chain planning and potentially lower logistics costs.
However, the actual benefits will depend on the final approval of the proposed amendment, the operational readiness of the selected facilities and the procedures followed for import clearance.
The Centre's proposal to add 10 new locations marks a potential expansion of India's import infrastructure for medicines and medical devices. If implemented, it could provide healthcare businesses with more choices for bringing imported products into the country and moving them efficiently to their intended destinations.
